
Bigtaz 2.25gm Injection
Marketer
Meritus Life Care Pvt Ltd
Salt Composition
Piperacillin (2gm) + Tazobactum (0.25 gm)
Overview Bigtaz 2.25gm Injection
Ceftazidime/Tazobactam 2.25g Injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered by a healthcare provider, dosage and frequency are determined by your doctor based on illness severity. Strict adherence to the prescribed regimen is crucial. Common side effects may include nausea, vomiting, diarrhea, rash, and injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects warrant immediate medical attention. Prior to use, inform your doctor of any antibiotic allergies, kidney or liver issues; dosage adjustments or alternative medications may be necessary. Generally considered safe during pregnancy and breastfeeding under medical guidance.
Uses of Bigtaz 2.25gm Injection
Infections caused by bacteria
Major Benefits of Bigtaz 2.25gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Bigtaz 2.25gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Bigtaz 2.25gm Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Bigtaz 2.25gm Injection works:
The injectable formulation Bigtaz 2.25gm combines piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam's role is to counteract bacterial resistance mechanisms, thereby bolstering piperacillin's antimicrobial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Bigtaz 2.25gm Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Bigtaz, 2.25gm dose, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; however, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation compatibility studies indicate that the 2.25-gram Bigtaz injection poses minimal risk during breastfeeding. Research in humans shows negligible transfer of the medication into breast milk, suggesting no significant harm to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Bigtaz 2.25gm Injection on driving ability is undetermined. Refrain from driving if you experience any symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Bigtaz 2.25gm Injection cautiously. Dosage modification of Bigtaz 2.25gm Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Bigtaz 2.25gm Injection in individuals with liver impairment appears to present a low risk. Current evidence indicates dose modification may be unnecessary, however, medical advice should be sought.
What if you forget to take Bigtaz 2.25gm Injection :
Should you inadvertently skip a dose of Bigtaz 2.25gm Injection, seek immediate medical advice.
Facts to Know About Bigtaz 2.25gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
